US Broker Ratings

Veracyte, Inc. (VCYT) Stock Analysis: Riding the Wave of Revenue Growth in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its solid revenue growth and expanding portfolio..

Kymera Therapeutics, Inc. (KYMR)

⚠️ No article content returned.

..

Enovis Corporation (ENOV) Stock Analysis: Healthcare Innovator with a 62.54% Potential Upside

Enovis Corporation (NYSE: ENOV), a notable player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with its current market dynamics. With a market capitalization of..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 19.42% Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) is garnering considerable attention from investors, particularly due to its significant 19.42% potential upside based on current analyst ratings. As a key player in the..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Eyeing a 62.94% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) has caught the attention of investors with its significant potential upside of 62.94%. With its focus on behavioral healthcare services, Acadia plays a crucial..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 148% Upside Potential in the Biotech Sector

For investors with a keen eye on the biotechnology sector, Zai Lab Limited (NASDAQ: ZLAB) presents a compelling opportunity. Based in China, Zai Lab operates at the forefront of healthcare..

BioCryst Pharmaceuticals (BCRX) Stock Analysis: A Promising 198% Potential Upside in the Healthcare Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing the attention of investors with its significant growth potential in the healthcare sector. With a market capitalization of $1.44 billion, BioCryst is a..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech with 48% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out in the biotechnology sector with a compelling growth trajectory and a robust pipeline of products targeting rare diseases. Based in Coral Gables, Florida,..

Alvotech (ALVO) Stock Analysis: A 382% Potential Upside in the Biosimilar Market

Investors looking for opportunities in the healthcare sector may find Alvotech (NASDAQ: ALVO) an intriguing option, with a staggering potential upside of 382.63% based on analyst ratings. Operating out of..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Uncovering Growth Potential Amidst Biotech Volatility

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Switzerland-based biotechnology company, is making waves in the healthcare sector with its innovative approach to inflammatory diseases. Despite being a relatively young company, having been..

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a 29.71% Upside Potential in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, has caught the attention of investors with its promising growth trajectory and impressive analyst ratings. As a..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: 31.25% Potential Upside Ignites Investor Interest

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a leader in the biotechnology sector, is capturing investor attention with its promising potential upside of 31.25%. This neuroscience-focused biopharmaceutical company, based in Burnaby, Canada,..

Envista Holdings Corporation (NVST) Stock Analysis: Potential Upside and Strategic Market Position

Envista Holdings Corporation (NYSE: NVST) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista is recognized for..

Metsera, Inc. (MTSR) Stock Analysis: Evaluating the Potential -19.15% Downside Amid Healthcare Innovations

Metsera, Inc. (NASDAQ: MTSR) is a key player in the biotechnology sector, focusing on developing innovative treatments for obesity and related diseases. As a clinical-stage company, Metsera is at the..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Exploring a 73.61% Potential Upside in the Medical Devices Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the medical devices industry with its innovative solutions in the field of urology. Headquartered in San Jose, California, this surgical robotics..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A Promising 21% Potential Upside in the Biotech Arena

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a key player in the biotechnology sector, is making waves with its focus on central nervous system (CNS) disorders and rare diseases. With a current..

Sotera Health Company (SHC) Investor Outlook: Exploring a 12.8% Potential Upside with Strong Buy Ratings

Sotera Health Company (NYSE: SHC) stands as a key player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $4.77 billion, Sotera Health..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating the Biotechnology Space with Promising Growth Prospects

PTC Therapeutics, Inc. (NASDAQ: PTCT), a key player in the biotechnology sector, has been making waves with its strategic focus on rare disorders, offering a beacon of hope to patients..

Alkermes plc (ALKS) Stock Analysis: Exploring a 53% Potential Upside in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, is a notable entity within the healthcare sector, specifically focusing on the specialty and generic drug manufacturing industry. With a robust market..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Healthcare Innovator with 18% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) presents an intriguing opportunity for investors with its robust growth trajectory and strategic positioning in the healthcare sector. Specializing in the design and manufacture..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds